导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 36.15% | 82/4773 |
| 近一周 | 2.45% | 95/5465 |
| 近一月 | -6.00% | 3991/5421 |
| 近一季 | -9.69% | 3611/5231 |
| 近半年 | 26.87% | 99/4920 |
| 近一年 | 43.16% | 105/4394 |
| 近两年 | 202.06% | 83/2954 |
| 近三年 | 132.97% | 52/2253 |
| 成立以来 | 201.67% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.17% 3064/4961 |
103.79% 80/5312 |
- - |
- - |
| 2025 | 42.30% 704/4813 |
3.87% 1027/3635 |
0.01% 2776/4076 |
46.77% 514/4524 |
-6.67% 3726/4813 |
| 2024 | 23.80% 318/3463 |
-11.36% 2429/2808 |
0.52% 589/3014 |
16.97% 1299/3129 |
18.79% 63/3463 |
| 2023 | -1.79% 533/2656 |
17.46% 173/2280 |
-7.85% 1923/2385 |
-8.79% 1732/2515 |
-0.52% 219/2655 |
| 2022 | -33.89% 1709/2207 |
-19.93% 1507/1919 |
-0.35% 1617/2016 |
-17.56% 1614/2113 |
0.50% 1488/2208 |
| 2021 | 22.58% 139/1822 |
-13.45% 1156/1255 |
45.47% 8/1330 |
-5.97% 886/1466 |
3.55% 422/1822 |
| 2020 | 42.51% 265/1250 |
9.30% 27/1028 |
27.65% 126/1067 |
-3.41% 1090/1164 |
5.76% 775/1184 |
| 2019 | - - |
- - |
- - |
21.73% 3/850 |
18.10% 9/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 国联安中证半导体ETF联接A VS. 长安沪深300非周期A(740101) |